• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION VIGILANT X4 CRT-D; IMPLANTABLE DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION VIGILANT X4 CRT-D; IMPLANTABLE DEVICE Back to Search Results
Model Number G247
Device Problems Pacing Problem (1439); Failure to Read Input Signal (1581); Unexpected Therapeutic Results (1631); Under-Sensing (1661)
Patient Problems Cardiac Arrest (1762); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/30/2022
Event Type  Injury  
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) undersensed the patients ventricular fibrillation (vf) which led to delay in therapy.Upon further review, it was noted there was some inappropriate ventricular pacing being delivered during the ventricular fibrillation (vf) episode.Additionally, the vf was quite fine.Currently, the patient is hospitalized on extracorporeal membrane oxygenation (ecmo).At this time, the device remains in service.
 
Manufacturer Narrative
Correction to b2, and h6 fields (patient code and impact code).
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) undersensed the patients ventricular fibrillation (vf) which led to delay in therapy.Upon further review, it was noted there was some inappropriate ventricular pacing being delivered during the ventricular fibrillation (vf) episode.Additionally, the vf was quite fine.Currently, the patient is hospitalized on extracorporeal membrane oxygenation (ecmo).At this time, the device remains in service.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) undersensed the patients ventricular fibrillation (vf) which led to delay in therapy.Upon further review, it was noted there was some inappropriate ventricular pacing being delivered during the ventricular fibrillation (vf) episode.Additionally, the vf was quite fine.Currently, the patient is hospitalized on extracorporeal membrane oxygenation (ecmo).At this time, the device remains in service.
 
Manufacturer Narrative
The returned device was thoroughly inspected and analyzed upon receipt at our post market quality assurance laboratory.Dimensional analysis of the header was completed.Each port measured as expected.The device was then exposed to simulated heart load conditions, and the defibrillation, pacing, and sensing functions were tested.Impedance testing was completed, and all measurements were within normal limits.The device operated appropriately with no interruptions in therapy output at the returned programmed settings.A series of electrical tests was also performed, and again, normal device function was observed.Analysis did not identify any device characteristics that would have caused or contributed to the reported clinical observations.Correction to b2, and h6 fields (patient code and impact code).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIGILANT X4 CRT-D
Type of Device
IMPLANTABLE DEVICE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key15164618
MDR Text Key297242719
Report Number2124215-2022-29070
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526589287
UDI-Public00802526589287
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010012/S436
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 11/16/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date06/28/2021
Device Model NumberG247
Device Catalogue NumberG247
Device Lot Number219294
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/27/2022
Initial Date FDA Received08/04/2022
Supplement Dates Manufacturer Received09/15/2022
11/07/2022
Supplement Dates FDA Received09/26/2022
11/16/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/05/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Life Threatening;
Patient Age47 YR
Patient SexMale
-
-